These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19501510)

  • 41. SAR maps: a new SAR visualization technique for medicinal chemists.
    Agrafiotis DK; Shemanarev M; Connolly PJ; Farnum M; Lobanov VS
    J Med Chem; 2007 Nov; 50(24):5926-37. PubMed ID: 17958407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent agonists of the Hedgehog signaling pathway.
    Brunton SA; Stibbard JH; Rubin LL; Guicherit OM; Kruse LI; Price S; di Lucrezia R; MacKinnon CH; Avery A; Park Y; Buxton D; Boyd EA
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4308-11. PubMed ID: 19500978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review.
    Restrepo RD
    Respir Care; 2009 Aug; 54(8):1058-81. PubMed ID: 19650947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective effects of adenosine A2A agonist during hemorrhagic shock: a simple intervention may result in a complex response.
    Ramakers BP; Riksen NP; van der Hoeven JG; Smits P; Pickkers P
    Crit Care Med; 2006 Dec; 34(12):3059; author reply 3059-60. PubMed ID: 17130711
    [No Abstract]   [Full Text] [Related]  

  • 45. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
    Gillespie RJ; Adams DR; Bebbington D; Benwell K; Cliffe IA; Dawson CE; Dourish CT; Fletcher A; Gaur S; Giles PR; Jordan AM; Knight AR; Knutsen LJ; Lawrence A; Lerpiniere J; Misra A; Porter RH; Pratt RM; Shepherd R; Upton R; Ward SE; Weiss SM; Williamson DS
    Bioorg Med Chem Lett; 2008 May; 18(9):2916-9. PubMed ID: 18406614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.
    Aki C; Chao J; Ferreira JA; Dwyer MP; Yu Y; Chao J; Merritt RJ; Lai G; Wu M; Hipkin RW; Fan X; Gonsiorek W; Fosseta J; Rindgen D; Fine J; Lundell D; Taveras AG; Biju P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4446-9. PubMed ID: 19525110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases.
    Elzein E; Kalla RV; Li X; Perry T; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
    J Med Chem; 2008 Apr; 51(7):2267-78. PubMed ID: 18321039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Jahangir A; Alam M; Carter DS; Dillon MP; Bois DJ; Ford AP; Gever JR; Lin C; Wagner PJ; Zhai Y; Zira J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1632-5. PubMed ID: 19231178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3).
    Kuduk SD; Chang RK; Wai JM; Di Marco CN; Cofre V; DiPardo RM; Cook SP; Cato MJ; Jovanovska A; Urban MO; Leitl M; Spencer RH; Kane SA; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4059-63. PubMed ID: 19553111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New benzylureas as a novel series of potent, nonpeptidic vasopressin V2 receptor agonists.
    Yea CM; Allan CE; Ashworth DM; Barnett J; Baxter AJ; Broadbridge JD; Franklin RJ; Hampton SL; Hudson P; Horton JA; Jenkins PD; Penson AM; Pitt GR; Rivière P; Robson PA; Rooker DP; Semple G; Sheppard A; Haigh RM; Roe MB
    J Med Chem; 2008 Dec; 51(24):8124-34. PubMed ID: 19053774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.
    Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position.
    Johns BA; Weatherhead JG; Allen SH; Thompson JB; Garvey EP; Foster SA; Jeffrey JL; Miller WH
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1807-10. PubMed ID: 19217284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles.
    Dushin RG; Nittoli T; Ingalls C; Boschelli DH; Cole DC; Wissner A; Lee J; Yang X; Morgan P; Brennan A; Chaudhary D
    Bioorg Med Chem Lett; 2009 May; 19(9):2461-3. PubMed ID: 19345579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.
    Rodríguez Sarmiento RM; Nettekoven MH; Taylor S; Plancher JM; Richter H; Roche O
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4495-500. PubMed ID: 19524437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allosteric inhibitors of Akt1 and Akt2: discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity.
    Li Y; Liang J; Siu T; Hu E; Rossi MA; Barnett SF; Defeo-Jones D; Jones RE; Robinson RG; Leander K; Huber HE; Mittal S; Cosford N; Prasit P
    Bioorg Med Chem Lett; 2009 Feb; 19(3):834-6. PubMed ID: 19097777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
    Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use.
    By Y; Durand-Gorde JM; Condo J; Lejeune PJ; Mallet B; Carayon P; Guieu R; Ruf J
    Mol Immunol; 2009 Jan; 46(3):400-5. PubMed ID: 19041138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.
    Bonjoch J; Diaba F; Pagès L; Pérez D; Soca L; Miralpeix M; Vilella D; Anton P; Puig C
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4299-302. PubMed ID: 19505824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA; Schumock GT; Bartle B; Pickard AS
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.